Cargando…
Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small‐cell lung cancer patients: A population‐based study
BACKGROUND: Patients with small‐cell lung cancer (SCLC) have a high incidence of synchronous brain metastases (SBM) and a poor prognosis, which causes a heavy burden of morbidity and mortality. A better understanding of the demographic and tumor‐specific characteristics of these patients is critical...
Autores principales: | Zhou, Gang, Zhang, Zhiyuan, Yu, Peng, Geng, Ruixuan, Wang, Guige, Ma, Wenbin, Gao, Jun, Zheng, Zhibo, Li, Yongning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883432/ https://www.ncbi.nlm.nih.gov/pubmed/35831985 http://dx.doi.org/10.1002/cam4.4978 |
Ejemplares similares
-
Prognosis of Non-Small Cell Lung Cancer with Synchronous Brain Metastases Treated with Gamma Knife Radiosurgery
por: Kong, Doo-Sik, et al.
Publicado: (2006) -
Surgical Treatment of Non-Small Cell Lung Cancer with Isolated Synchronous Brain Metastases
por: I, Hoseok, et al.
Publicado: (2006) -
Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019) -
Epidemiology of synchronous brain metastases
por: Singh, Raj, et al.
Publicado: (2020) -
The analysis of prognosis factor in patients with non-small cell lung cancer receiving pneumonectomy
por: Wang, Guige, et al.
Publicado: (2020)